ALDO TULLIO IACONO
Medical Practice in Pittsburgh, PA
License number
Pennsylvania MD048293L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Pittsburgh, PA 15238
Personal information
See more information about ALDO TULLIO IACONO at radaris.comName
Address
Phone
105 Glen Haven Ln, Pittsburgh, PA 15238
105 Glen Haven Ln, Pittsburgh, PA 15238
419 Noble St, Pittsburgh, PA 15232
Professional information
Aldo Iacono, Baltimore MD
Work:
University of Maryland
22 S Greene St, Baltimore, MD 21263 University of Maryland
419 W Redwood St, Baltimore, MD 21201 Univ. of Pittsburgh Physicians
3347 Forbes Ave, Pittsburgh, PA 15213 Univ. Of Md Medical System
10 N Greene St, Baltimore, MD 21201
22 S Greene St, Baltimore, MD 21263 University of Maryland
419 W Redwood St, Baltimore, MD 21201 Univ. of Pittsburgh Physicians
3347 Forbes Ave, Pittsburgh, PA 15213 Univ. Of Md Medical System
10 N Greene St, Baltimore, MD 21201
Use Of Aerosolized Cyclosporine For Prevention And Treatment Of Pulmonary Disease
US Patent:
2002000, Jan 17, 2002
Filed:
Feb 5, 1999
Appl. No.:
09/244792
Inventors:
ALDO T. IACONO - PITTSBURGH PA, US
International Classification:
A61K038/00, A61K031/47
US Classification:
514/011000, 514/009000, 424/045000
Abstract:
The present invention relates to methods and compositions for prevention of graft rejection in lung transplant recipients and for treatment of subjects with pulmonary disorders. Specifically, the methods and compositions of the invention provide a means for inhibiting immune response mediated inflammatory processes in the lungs. The method of the invention comprises the administration of aerosolized cyclosporine for prevention of acute and/or chronic refractory rejection in lung transplant patients. The invention further provides for the use of aerosolized cyclosporine to treat subjects having immunologically mediated inflammatory pulmonary disorders including, but not limited to, asthma, cystic fibrosis, idiopathic pulmonary fibrosis, chronic bronchitis and allergic rhinitis. The present invention, by enabling a method for the use of aerosolized cyclosporine for inhibiting pulmonary inflammation leading to prevention of graft rejection and treatment of pulmonary disorders, provides a safer and less toxic treatment than those methods that utilize systemic administration of cyclosporine.
Use Of Aerosolized Cyclosporine For Prevention And Treatment Of Pulmonary Disease
US Patent:
2009026, Oct 22, 2009
Filed:
Apr 30, 2009
Appl. No.:
12/433231
Inventors:
ALDO T. IACONO - Pittsburgh PA, US
International Classification:
A61K 9/12, A61P 37/06, A61K 38/13
US Classification:
424 45, 514 11
Abstract:
The present invention relates to methods and compositions for prevention of graft rejection in lung transplant recipients and for treatment of subjects with pulmonary disorders. Specifically, the methods and compositions of the invention provide a means for inhibiting immune response mediated inflammatory processes in the lungs. The method of the invention comprises the administration of aerosolized cyclosporine for prevention of acute and/or chronic refractory rejection in lung transplant patients. The invention further provides for the use of aerosolized cyclosporine to treat subjects having immunologically mediated inflammatory pulmonary disorders including, but not limited to, asthma, cystic fibrosis, idiopathic pulmonary fibrosis, chronic bronchitis and allergic rhinitis. The present invention, by enabling a method for the use of aerosolized cyclosporine for inhibiting pulmonary inflammation leading to prevention of graft rejection and treatment of pulmonary disorders, provides a safer and less toxic treatment than those methods that utilize systemic administration of cyclosporine.